Tag: Depression

A researcher and service user Stevie Lewis recounts her own experience with antidepressant withdrawal and what she wishes her doctors knew.

Researchers find a lack of current literature on safe, effective ways to manage antidepressant withdrawal and make suggestions for future research.

An analysis of FDA adverse event reports related to esketamine shows the potential for negative effects such as suicidal and self-injurious ideation.

Within the current mental health paradigm, profound grief is often shoved into the universal category of depression and treated as a malfunction according to the biomedical model.

In his attacks against the British Psychological Society's report "Understanding Depression," Dr. Pies falls into his own trap: "There are none so blind as those who will not see."

The promotion of SSRI antidepressant use began with the pharmaceutical industry and occurs despite evidence that these drugs are harmful, not helpful, in children and adolescents.

The medicalisation of our emotional lives has led to a horrific cultural shift in which we, and our children, have become alienated from and suspicious of our emotions, chipping away at our natural resilience.

A new study offers promising results for psilocybin-assisted psychotherapy for depression.

During my 96-hour hold in the psych unit—despite that I was rational and a danger to no one—I was made to feel ashamed and somehow unclean. I went home feeling more depressed than ever.

Researchers review a new synthesis of the existing evidence and conclude that the harms of antidepressants outweigh any benefits.

This piece is the second of a two-part essay about suicide, diagnosis, what doesn't help, and what does help. This part is about barriers to seeking help and about the ways we actually can be of help to people who are considering suicide.

This piece is the first of a two-part essay about suicide, diagnosis, what doesn't help, and what does help. This part is about suicide, diagnosis, and some of what fails to help.

A new review of strategies to support both patients and practitioners through the process of discontinuing antidepressants.

Once an appropriate statistical method was used, the study findings were “no longer valid,” according to the editors of JAMA and JAMA Psychiatry.

Trials of antidepressants for relapse prevention are confounded by withdrawal effects caused by the drugs.

There are three steps to modern psychiatry’s successful business formula: 1. Get people to think that they’re stupid even though they’re smart. 2. Train them to actually think stupidly. 3. Directly stupidify them with chemicals.

It seems more and more common for people who consider themselves mental health advocates to make the argument that “mental illness is like physical illness.” Have you heard this “depression is like diabetes” tactic? I have a hard time seeing how this is advocating for those in emotional distress.

Inside the hospital, I was a social butterfly and knew practically everyone on my wing, but at home, I was a nobody and a loner. If only I had the energy to fake it one hundred percent of the time, then nobody would suspect a thing.

The spurious chemical imbalance theory of depression is arguably the most destructive thing that psychiatry has ever done. Worldwide, millions of individuals are taking antidepressants, often with a cocktail of other drugs, because they have been told the blatant falsehood that they need the pills to combat a brain illness.

Researchers suggest that the pharmaceutical industry had a vested interest in using the term “discontinuation” in order to hide the severity of physical dependence and withdrawal reactions many people experience from antidepressants.

In a new study, researchers found no evidence of antidepressant group variance, which means that there's no particular group of patients who improve more than others on the drug.

A review of 73 antidepressant studies finds that 12% more people drop out of clinical trials when taking antidepressants than when taking placebo, evidence that many find the adverse effects of antidepressants difficult to tolerate.

In a new study published in JAMA Psychiatry, researchers investigated whether they could use EEG (electroencephalograph) technology to predict whether people would feel better...

In-depth interviews find that those who screened positive for depression did not explain their experience in terms of diagnostic symptoms.

A network analysis of participants’ social media use and well-being reveals complex links with social capital but a minimal association with attentional control.